論文

査読有り
2013年2月

Risk of subsequent biliary malignancy in patients undergoing cyst excision for congenital choledochal cysts.

J Gastroenterol Hepatol
  • Ohashi Taku
  • Wakai Toshifumi
  • Kubota Masayuki
  • Matsuda Yasunobu
  • Arai Yuhki
  • Ohyama Toshiyuki
  • Nakaya Kengo
  • Okuyama Naoki
  • Sakata Jun
  • Shirai Yoshio
  • Ajioka Yoichi
  • 全て表示

28
2
開始ページ
243
終了ページ
247
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1111/j.1440-1746.2012.07260.x

BACKGROUND AND AIM: The aim of this study was to elucidate the risk of subsequent biliary malignancy in patients undergoing cyst excision for congenital choledochal cysts. METHODS: A retrospective analysis of 94 patients who had undergone cyst excision for congenital choledochal cysts was conducted. The median age at the time of cyst excision and median follow-up time after cyst excision were 7 years and 181 months, respectively. RESULTS: Biliary tract cancer developed in four patients at 13, 15, 23, and 32 years after cyst excision. The cumulative incidences of biliary tract cancer at 15, 20, and 25 years after cyst excision were 1.6%, 3.9%, and 11.3%, respectively. The sites of biliary tract cancer were the intrahepatic (n = 2), hilar (n = 1), and intrapancreatic (n = 1) bile ducts. Of the four patients with biliary tract cancer after cyst excision, three patients underwent surgical resection and one patient received chemo-radiotherapy. The overall cumulative survival rates after treatment in the four patients with biliary tract cancer were 50% at 2 years and 25% at 3 years, with a median survival time of 15 months. CONCLUSIONS: The risk of subsequent biliary malignancy in pat

リンク情報
DOI
https://doi.org/10.1111/j.1440-1746.2012.07260.x
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/22989043
ID情報
  • DOI : 10.1111/j.1440-1746.2012.07260.x
  • ISSN : 1440-1746
  • PubMed ID : 22989043

エクスポート
BibTeX RIS